Dye & Durham Shares Sink With Plans to Reduce Convertible Debt
By Robb M. Stewart
Dye & Durham's shares were sharply lower after the Canadian legal-practice management software company said it was taking steps to strengthen its balance sheet and reduce convertible debt.
In Friday afternoon trading, the shares were 7.5% lower at C$10.93, widening the fall so far this year to 33%.
Dye & Durham, which affirmed its financial performance in the first quarter of the fiscal year was in line with expectations, said it was refinancing a sizable portion of its convertible debt on favorable terms. When completed, the balance of original convertible debentures will be down by 95 million Canadian dollars ($69 million), decreasing overall convertible debt by C$10 million.
The move will give the company greater flexibility to refinance and strengthen the balance sheet going forward, Chief Executive Matthew Proud said.
As part of the process, the company will offer to cancel up to C$95 million of its issued and outstanding 3.75% convertible unsecured debentures due March 1, 2026, in exchange for up to about C$32.3 million in cash. It will retire the debt at C$750 for every C$1,000 principal amount.
Dye & Durham also will issue C$20.4 million of new debentures to help fund a portion of the cash payable under its offer. Canaccord Genuity will have the right to buy up to C$5 million in new debentures to cover any overallotments. The new debentures will bear interest at 6.50% a year, payable semi-annually, and will be convertible at any time at C$40 a share.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
October 20, 2023 14:08 ET (18:08 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks